WellPoint to unload 1-800-Contacts unit
Financial terms of the sale to Boston-based private equity firm Thomas H. Lee Partners LP weren’t disclosed. WellPoint paid a reported $900 million to buy the company in June 2012.
Financial terms of the sale to Boston-based private equity firm Thomas H. Lee Partners LP weren’t disclosed. WellPoint paid a reported $900 million to buy the company in June 2012.
In a warning shot to investors, the pharmaceutical giant says it expects “2014 to be the most financially challenging year of Lilly’s current period of patent expirations.”
It’s a challenging time to be a hospital CEO, but when Jonathan Nalli takes the helm of St. Vincent Health, he’ll have about as strong a financial hand as anybody to play.
When Gov. Mike Pence tries next month to negotiate a Medicaid expansion deal in a meeting with the Obama administration, it will be a clash of the conservative and liberal approaches to fighting poverty.
Obamacare has officially arrived, but both conservatives and liberals are calling it awful. That means the real debate over health reform is just beginning.
After a troubled rollout, President Barack Obama's health care overhaul now faces its most personal test: How will it work as people seek care under its new mandates?
The so-called "young invincibles" are so important to the success of the Affordable Care Act that supporters and detractors are spending millions to reach them.
The Supreme Court has thrown a hitch into President Barack Obama's new health care law by blocking a requirement that some religion-affiliated organizations provide health insurance that includes birth control.
Jonathan S. Nalli, 39, has led Porter Health System in Valparaiso since 2007. He will take over the 22-hospital St. Vincent system on Feb. 1.
IU Health has decided to still give patients the same “in network” co-pays and deductibles that UnitedHealthcare had negotiated under the expiring contracts, keeping patients’ costs the same until a new deal is reached.
Endocyte Inc. plans to raise as much as $60 million by offering new shares to the public “from time to time,” to help it develop additional drugs.
The windfall comes at a critical moment for health care reform, which becomes “real” for many Americans on Jan. 1 as coverage through the insurance exchanges and key patient protections kick in.
After suffering for years with decrepit heating and ventilating systems, Wishard, the busiest hospital in the state, finally got a new home. And a new name.
The deadline to enroll in plans that begin Jan. 1 now is midnight Tuesday for most of the U.S. On Monday, healthcare.gov fielded nearly 50,000 simultaneous visitors, triggering a queuing system.
Small business dumping, the uncertainty of Obamacare's exchanges, and the certainty of Obamacare's taxes will take a bite out of WellPoint's earnings next year. But company executives remain bullish on Obamacare's long-term impact.
In the Christmas spirit of hope, I’m offering a reading list of several optimistic reports about health care reform—even though many of my recent posts, and the mood of the country in general, have been decidedly downbeat.
The Obama administration has been releasing more price and quality information, but it is coming in a rather useless form for patients. That’s a problem for the prospects of consumer-driven health care.
Eli Lilly and Co., Pfizer Inc., Sanofi and other large drugmakers will keep paying doctors to give talks about their products, leaving GlaxoSmithKline Plc alone for now in its decision to halt such compensation.
Consumers who enroll in health plans through the new U.S. exchanges will get 10 extra days to pay their first premiums and still gain coverage effective Jan. 1, an insurance company trade group said Wednesday.
Fifteen years after Pfizer Inc.’s Viagra changed the sexual equation for older men, the blockbuster impotence drug is set to become available in a less expensive generic form as early as 2017.